Skip to main content

Townsend Richard Nolan's Form 4/A amendment

Amended

Lexeo Therapeutics, Inc.LXEO · filed Sep 10, 2025

Accession no.
0001415889-25-024104
Filed
Sep 10, 2025
Trade date
Aug 18, 2025
Filing delay
23 days
Rule 10b5-1 plan
Not checked
Original filed
Aug 20, 2025

This filing lists 1 non-derivative transaction. Open-market sales total $5.21K. It was filed 23 days after the trade.

This amendment replaces 0001415889-25-022473 (filed Aug 20, 2025).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Townsend Richard NolanCIK 0001995218Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2025Common StockSSaleDisposed−1,115$4.67−$5,207.05220,058Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F2

On August 20, 2025, the reporting person filed a Form 4 which inadvertently reported the disposition of 2,735 securities. In fact, as reported in this amendment, the reporting person disposed of 1,115 shares of Common Stock on August 18, 2025.

F3

Includes 131,092 Restricted Stock Units.

Read the full filing on SEC EDGAR (opens in a new tab)